KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
26 December 05:59 AM

Sector News

Photo Archive
4 November 10:12 AM SPIMACO posts SAR 1.3bn revenues in 9M-25; profits leap 220%
Riyadh - Mubasher: The net profits of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) reached SAR 154.70 million in the first nine months (9M) of 2025. The registered net profits jumped by 220.28% from SAR 48.30 …
Financial Results
Photo Archive
29 October 07:42 AM Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) signed a non-binding term sheet with Pharmaceutical Investment Company (Lifera), a Public Investment Fund (PIF) entity, on 27 October. The term sheet aims to form a joint …
Companies Investments
Photo Archive
23 October 01:09 PM Jamjoom Pharma’s net profits near SAR 396m in 9M-25
Riyadh – Mubasher: The net profits after tax of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) reached SAR 395.73 million in the first nine months (9M) of 2025, an annual rise of 29.78% from SAR 304.92 million. The group recorded 12.96% …
Financial Results
Photo Gallery
5 October 08:18 AM Jamjoom Pharma launches new brand identity to accelerate regional growth
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) rolled out its new corporate brand identity, marking the next phase of its strategic evolution towards being a leading global player in the pharmaceutical industry. The …
Companies Investments
Photo Archive
16 September 09:12 AM SPIMACO inks SAR 200m credit facility agreement with SNB
Riyadh - Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) obtained a Sharia-compliant facility worth SAR 200 million from the Saudi National Bank (SNB). The funding, secured on 15 September 2025, will be …
Companies Investments
Photo Gallery
16 September 08:46 AM Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a strategic commercialization agreement with Bio-Thera Solutions Limited, a global biopharmaceutical firm specializing in innovative therapies and biosimilars. …
Companies Investments
Photo Archive
6 August 05:34 PM SPIMACO reports 93% surge in H1-25 profits; accumulated losses unveiled
Riyadh - Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) achieved net profits of SAR 111.10 million in the first half (H1) of 2025, marking a 92.88% year-on-year (YoY) leap from SAR 57.60 million. Revenues …
Financial Results
Photo Archive
1 July 05:15 PM Jamjoom Pharma appoints new Chairman, Vice Chairman
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has named Mahmoud Yousuf Jamjoom as the board’s Chairman for the next three years. The board also announced Ahmed Yousuf Jamjoom as the Vice Chairman, according to a …
Corporate Actions
Photo Archive
12 May 06:42 PM SPIMACO’s net profits leap 90% in Q1-25
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) logged net profits worth SAR 75.10 million in the first quarter (Q1) of 2025. The generated earnings were higher by 90.12% year-on-year (YoY) than SAR …
Financial Results
Photo Archive
30 April 09:16 AM Jamjoom Pharma logs SAR 157m net profits in Q1-25
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits amounting to SAR 157.03 million in the first quarter (Q1) of 2025, an annual growth of 52.50% from SAR 102.97 million. Revenues soared by 18.69% to …
Financial Results
Photo Archive
13 April 09:30 AM Avalon Pharma unveils SAR 25m cash dividends for H2-24
Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million for the second half (H2) of 2024, according to a bourse filing. The Saudi group will disburse SAR 1.25 …
Board of Directors
Photo Archive
8 April 09:50 AM SPIMACO appoints Chairman, Vice Chairman
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) unveiled key appointments for a new board term that will end on 2 April 2029. SPIMACO named Khalid Abdulrahman Alqwaiz as the board’s Chairman for the …
Corporate Actions
Photo Gallery
25 February 08:42 PM Jamjoom Pharma registers 22% higher profits backed by expansion in Egypt
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted 21.93% higher net profits at SAR 356.52 million in 2024, compared to SAR 292.40 million in 2023. Revenues jumped by 19.77% year-on-year (YoY) to SAR 1.31 billion as …
Cash Dividends
Photo Archive
19 January 04:05 PM SPIMACO rolls out SAR 164m deal
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) inked a SAR 164.05 million agreement on 16 January 2025. SPIMACO penned the deal with Ibrahim Al Hudhaifi International Company to sell and distribute …
Companies Investments
Photo Gallery
15 January 03:28 PM Jamjoom Pharma partakes in 43rd J.P. Morgan Healthcare Conference 2025
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) is participating in the 43rd Annual J.P. Morgan Healthcare Conference that is taking place in the US, according to a press release. The conference is being held on 13-16 …
Event
Photo Archive
5 January 10:09 PM TASI expected to trade between 11,300 to 13,300pts in 2025 – Report
Riyadh – Mubasher: SNB Capital, a regional financial institution, recently projected in a report that the benchmark All Share Index (TASI) of the Saudi Exchange (Tadawul) would trade between 11,300 to 13,300 points (pts) in 2025, reflecting a …
Trading Activities
Photo Archive
11 November 2024 04:37 PM SPIMACO’s profits leap 279% in 9M-24
Riyadh – Mubasher: The net profits of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) enlarged by 278.77%  yearly to SAR 67.80 million in the first nine months (9M) of 2024 from SAR 17.90 million. The Saudi group …
Financial Results
Photo Archive
27 October 2024 00:40 PM Jamjoom Pharma posts SAR 305m net profits in 9M-24
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits valued at SAR 304.92 million in the first nine months (9M) of 2024, marking a 22.90% year-on-year (YoY) leap from SAR 247.92 million. The revenues hit …
Financial Results
Photo Archive
7 August 2024 02:47 PM Jamjoom Pharma’s profits rise 23% in H1-24; dividends unveiled
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged net profits amounting to SAR 209.92 million in the first half (H1) of 2024, marking an annual plunge of 22.99% from SAR 170.67 million. The revenues hit SAR 731.20 …
Financial Results
Photo Archive
31 July 2024 11:58 AM Avalon Pharma’s board approves dividends for H1-24
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) is set to disburse cash dividends worth SAR 15 million, equivalent to 7.50% of the capital, for the first half (H1) of 2024. Avalon Pharma will pay out a dividend of …
Board of Directors
Photo Archive
9 July 2024 11:49 AM Avalon Pharma obtains SAR 70m from Emirates NBD
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) secured a Sharia facility amounting to SAR 70 million from Emirates NBD on 8 July 2024. The Saudi company obtained the loan for one year to finance its operations, …
Companies Investments
Photo Archive
8 July 2024 09:15 AM Jamjoom Pharma secures facility deal for unit in Algeria
Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to support the issuance of a credit facility for its joint venture (JV) in Algeria, Jamjoom Algeria Lil Dawa SPA. A …
Companies Investments
Photo Archive
5 June 2024 11:33 AM Jamjoom Pharma’s shareholders approve annual dividends for 2023
Riyadh – Mubasher: The extraordinary general meeting (EGM) of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) approved cash dividends amounting to SAR 105 million for the second half (H2) of 2023. The total dividends distributed and …
Cash Dividends
Photo Archive
9 May 2024 00:08 PM Jamjoom Pharma registers SAR 103m net profits in Q1-24
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved 22% year-on-year (YoY) higher net profits at SAR 102.96 million in the first quarter (Q1) of 2024, versus SAR 84.40 million. Revenues amounted to SAR 385.46 …
Financial Results
Photo Archive
4 April 2024 02:12 PM Jamjoom Pharma’s board proposes SAR 105m dividends
Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recommended the distribution of SAR 105 million in cash dividends for 2023. The suggested dividends amount to SAR 1.50 per share to be distributed to 70 …
Cash Dividends